274693-27-5

  • Product NameTICAGRELOR
  • Molecular FormulaC23H28F2N6O4S
  • Molecular Weight522.576
  • Purity99%
  • Appearancewhite powder
Inquiry

Product Details

Quick Details

  • CasNo: 274693-27-5
  • Molecular Formula: C23H28F2N6O4S
  • Appearance: white powder
  • Purity: 99%

Top quality factory supply 274693-27-5 TICAGRELOR at low price We supply high quality Ticagrelor (CAS 274693-27-5), in stock, factory directly supply to clients, lower prices, more competitiveness.

What is the Ticagrelor ?

Ticagrelor is white powder, while it's Molecular Formula is C23H28F2N6O4S. Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).

What is the CAS number for Ticagrelor ?

The CAS number of Ticagrelor is 274693-27-5.

More information of Ticagrelor 274693-27-5 are:

Synonyms

AR-C126532XX;AZD 6140;1,2-Cyclopentanediol,3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-,(1S,2S,3R,5S)-;

CAS Number

274693-27-5

Molecular Formula

C23H28F2N6O4S

Molecular Weight

522.576

Density

1.676 g/cm3

Boiling Point

777.551 °C at 760 mmHg

Flash Point

424.048 °C

HS CODE

29335990

PSA

163.74000

LogP

2.08670

Pka

13.26±0.70(Predicted)

What is Ticagrelor (274693-27-5) used for?

In December 2010, the P2Y12 receptor antagonist ticagrelor (also known as AZD6140) was approved in Europe for the treatment of acute coronary syndrome (ACS), a condition that covers several clinical symptoms with the potential to cause acute myocardial ischemia (MI). ADP binds to two purinergic receptors, the P2Y1 and P2Y12 receptors. The action of ADP binding to the P2Y12 receptor results in activation of the GP Ⅱb/Ⅲa (integrin) receptor.GP Ⅱb/Ⅲa initiates and prolongs platelet aggregation, which in turn results in the cross-linking of platelets through fibrin and finally thrombus formation. Inhibition of ADP stimulation of the P2Y12 receptor has been found to be an effective strategy for managing the atherothrombotic events associated with ACS and potentially resulting from percutaneous coronary intervention (PCI, stent implantation) .

InChI:InChI=1/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15?,16?,17-,19-,20+/m0/s1

Articles related to Ticagrelor:

Article

Source

PROCESS FOR THE PREPARATION OF TICAGRELOR

-

Paragraph 11-13, (2021/12/28)

Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity

Goffin, Eric,Jacques, Nicolas,Lancellotti, Patrizio,Musumeci, Lucia,Nchimi, Alain,Pirotte, Bernard,Oury, Cécile

, (2020/09/11)

How to get the best price on Ticagrelor?

HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD is a quality supplier and manufacturer of Ticagrelor . You can buy high quality, low price Ticagrelor 274693-27-5 here. Contact us.

Relevant Products

*Product Name
CasNo
Quantity
Company Name
Phone
*Email
*Description
*Code
Items marked with * are mandatory
Submit